Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome

The incidence of metabolic syndrome is significantly higher in patients with irritable bowel syndrome (IBS), but the mechanisms involved remain unclear. Gut microbiota is causatively linked with the development of both metabolic dysfunctions and gastrointestinal disorders, thus gut dysbiosis in IBS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Lixiang, Xiao, Haitao, Lin, Chengyuan, Wong, Hoi Leong Xavier, Lam, Yan Y., Gong, Mengxue, Wu, Guojun, Ning, Ziwan, Huang, Chunhua, Zhang, Yijing, Yang, Chao, Luo, Jingyuan, Zhang, Lu, Zhao, Ling, Zhang, Chenhong, Lau, Johnson Yiu-Nam, Lu, Aiping, Lau, Lok-Ting, Jia, Wei, Zhao, Liping, Bian, Zhao-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435514/
https://www.ncbi.nlm.nih.gov/pubmed/37591886
http://dx.doi.org/10.1038/s41467-023-40552-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435514/
https://www.ncbi.nlm.nih.gov/pubmed/37591886
http://dx.doi.org/10.1038/s41467-023-40552-y

Ejemplares similares